The RNA binding protein tristetraprolin influences the activation state of murine dendritic cells

Molecular Immunology

Volumn 47, Issue 5, 2010, Pages 1161-1170

  Bros, Matthias ^a   Wiechmann, Nadine ^a   Besche, Verena ^a   Art, Julia ^b   Pautz, Andrea ^b   Grabbe, Stephan ^a   Kleinert, Hartmut ^b   Reske Kunz, Angelika B ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Autoimmunity; Dendritic cells; Tolerance; Tristetraprolin

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; GENE PRODUCT; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PROTEIN C FOS; PROTEIN MKP 1; RNA BINDING PROTEIN; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GENOTYPE; HEMATOPOIETIC STEM CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA STABILITY; T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD86; DENDRITIC CELLS; DUAL SPECIFICITY PHOSPHATASE 1; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-FOS; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; TRISTETRAPROLIN; UP-REGULATION;

MURINAE; MUS;

EID: 74449092718     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.11.002     Document Type: Article

References (37)

1. Adams S., O'Neill D.W., and Bhardwaj N. Recent advances in dendritic cell biology. J. Clin. Immunol. 25 (2005) 87-98
2. Bros M., Jährling F., Renzing A., Wiechmann N., Dang N.A., Sutter A., Ross R., Knop J., Sudowe S., and Reske-Kunz A.B. A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid. Blood 109 (2007) 3820-3829
3. Carballo E., Gilkeson G.S., and Blackshear P.J. Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction. J. Clin. Invest. 100 (1997) 986-995
4. Carballo E., Lai W.S., and Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281 (1998) 1001-1005
5. Carballo E., Lai W.S., and Blackshear P.J. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95 (2000) 1891-1899
6. Chen Y.L., Huang Y.L., Lin N.Y., Chen H.C., Chiu W.C., and Chang C.J. Differential regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by lipopolysaccharide in RAW264.7 cells. Biochem. Biophys. Res. Commun. 346 (2006) 160-168
7. Chi H., Barry S.P., Roth R.J., Wu J.J., Jones E.A., Bennett A.M., and Flavell R.A. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 2274-2279
8. Eberhardt W., Doller A.E., Akool S., and Pfeilschifter J. Modulation of mRNA stability as a novel therapeutic approach. Pharmacol. Ther. 114 (2007) 56-73
9. Emmons J., Townley-Tilson W.H., Deleault K.M., Skinner S.J., Gross R.H., Whitfield M.L., and Brooks S.A. Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. RNA 14 (2008) 888-902
10. Fechir M., Linker K., Pautz A., Hubrich T., Förstermann U., Rodriguez-Pascual F., and Kleinert H. Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene. Mol. Pharmacol. 67 (2005) 2148-2161
11. Frasca D., Landin A.M., Alvarez J.P., Blackshear P.J., Riley R.L., and Blomberg B.B. Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J. Immunol. 179 (2007) 918-927
12. Gisch K., Gehrke N., Bros M., Priesmeyer C., Knop J., Reske-Kunz A.B., and Sudowe S. Formalin-fixed Staphylococcus aureus particles prevent allergic sensitization in a murine model of type I allergy. Int. Arch. Allergy Immunol. 144 (2007) 183-196
13. Hinman M.N., and Lou H. Diverse molecular functions of Hu proteins. Cell. Mol. Life Sci. 65 (2008) 3168-3181
14. Hitti E., Iakovleva T., Brook M., Deppenmeier S., Gruber A.D., Radzioch D., Clark A.R., Blackshear P.J., Kotlyarov A., and Gaestel M. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol. Cell. Biol. 26 (2006) 2399-2407
15. Korhonen R., Linker K., Pautz A., Förstermann U., Moilanen E., and Kleinert H. Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase. Mol. Pharmacol. 71 (2007) 1427-1434
16. Li M., Zhang X., Zheng X., Lian D., Zhang Z.X., Ge W., Yang J., Vladau C., Suzuki M., Chen D., Zhong R., Garcia B., Jevnikar A.M., and Min W.P. Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J. Immunol. 178 (2008) 5480-5487
17. Linker K., Pautz A., Fechir M., Hubrich T., Greeve J., and Kleinert H. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res. 33 (2005) 4813-4827
18. Lin N., Lin C., and Chang C. Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 365 (2008) 69-74
19. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60 (1995) 1539-1545
20. Mahtani K.R., Brook M.J., Dean L., Sully G., Saklatvala J., and Clark A.R. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21 (2001) 6461-6469
21. Ogilvie R.L., Abelson M., Hau H.H., Vlasova I., Blackshear P.J., and Bohjanen P.R. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J. Immunol. 174 (2005) 953-961
22. Prechtel A.T., Chemnitz J., Schirmer S., Ehlers C., Langbein-Detsch I., Stülke J., Dabauvalle M.C., Kehlenbach R.H., and Hauber J. Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA element. J. Biol. Chem. 281 (2006) 10912-10925
23. Raghavan A., Robison R.L., McNabb J., Miller C.R., Williams D.A., and Bohjanen P.R. HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J. Biol. Chem. 276 (2001) 47958-47965
24. Randolph G.J., Jakubzick C., and Qu C. Antigen presentation by monocytes and monocyte-derived cells. Curr. Opin. Immunol. 20 (2008) 52-60
25. Ray N., Kuwahara M., Takada Y., Maruyama K., Kawaguchi T., Tsubone H., Ishikawa H., and Matsuo K. c-Fos suppresses systemic inflammatory response to endotoxin. Int. Immunol. 18 (2006) 671-677
26. Salojin K.V., Owusu I.B., Millerchip K.A., Potter M., Platt K.A., and Oravecz T. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 176 (2006) 1899-1907
27. Scheicher C., Mehlig M., Zecher R., and Reske K. Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. Methods 154 (1992) 253-264
28. Smits H.H., de Jong E.C., Wierenga E.A., and Kapsenberg M.L. Different faces of regulatory DCs in homeostasis and immunity. Trends Immunol. 26 (2005) 123-129
29. Stoecklin G., Stubbs T., Kedersha N., Wax S., Rigby W.F., Blackwell T.K., and Anderson P. MK2-induced tristetraprolin: 14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 23 (2004) 1313-1324
30. Stoecklin G., Tenenbaum S.A., Mayo T., Chittur S.V., George A.D., Baroni T.E., Blackshear P.J., and Anderson P. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J. Biol. Chem. 283 (2008) 11689-11699
31. Suzuki K., Nakajima H., Ikeda K., Maezawa Y., Suto A., Takatori H., Saito Y., and Iwamoto I. IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells. J. Exp. Med. 198 (2003) 1717-1727
32. Taylor G.A., Carballo E., Lee D.M., Lai W.S., Thompson M.J., Patel D.D., Schenkman D.I., Gilkeson G.S., Broxmeyer H.E., Haynes B.F., and Blackshear P.J. A pathogenic role for TNFα in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4 (1996) 445-454
33. + regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9 (2008) 239-244
34. Tchen C.R., Brook M., Saklatvala J., and Clark A.R. The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself. J. Biol. Chem. 279 (2004) 32393-32400
35. Wang X., and Liu Y. Regulation of innate immune response by MAP kinase phosphatase-1. Cell. Signal. 19 (2007) 1372-1382
36. + T cell memory responses. J. Immunol. 172 (2004) 6056-6074
37. Zal T., Volkmann A., and Stockinger B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180 (1994) 2089-2099